By selling its China business to AstraZeneca, FibroGen can focus on developing a prostate cancer drug and potentially ...
A rare surgery in Delhi is making headlines, highlighting remarkable willpower and a groundbreaking medical achievement.
Devendra Barlewar, a 47-year-old scientist, successfully received a rare third kidney transplant at Amrita Hospital, leaving him with five kidneys, on ...
Millions of Americans take proton pump inhibitors (PPIs) like Prilosec, Nexium, and Prevacid to manage acid reflux, heartburn, and gastroesophageal reflux disease (GERD).
AstraZeneca will obtain the full rights to Roxadustat in China, FibroGen said, adding that it will retain the US and other ...
Devendra Barlewar, a scientist from the Union Ministry of Defence, successfully underwent his third kidney transplant.
Lack of steady income can cause patients to face difficulties in bearing treatment costs that can reach up to RM40,000 a year ...
Medical experts reveal the surprising daily behaviors that harm kidney health, from common drinking habits to unexpected ...
The following is a summary of “Treating chronic kidney disease in Danish primary care: results from the observational ATLAS study,” published in the February 2025 issue of BMC Primary Care by ...
Modus Therapeutics Holding AB ("Modus Therapeutics") hereby publishes the year-end report for 2024. The report is available as an attached document and on the company's ...
Ondo State, Prof. Oluseyi Adejumo, has said the health system in Nigeria cannot keep up with the demands for continuous kidney replacement therapy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results